Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1992 1
1994 2
1995 3
1996 2
1998 1
2000 2
2001 3
2002 1
2004 4
2005 12
2006 6
2007 9
2008 9
2009 5
2010 8
2011 11
2012 7
2013 8
2014 6
2015 17
2016 11
2017 14
2018 7
2019 13
2020 17
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Results by year
Filters applied: . Clear all
Page 1
Development of innate lymphoid cells.
Zook EC, Kee BL. Zook EC, et al. Among authors: kee bl. Nat Immunol. 2016 Jun 21;17(7):775-82. doi: 10.1038/ni.3481. Nat Immunol. 2016. PMID: 27328007 Review.
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V, Bagadia P, Granja JM, Satpathy AT, Kulkarni DH, Davidson JT 4th, Wu R, Patel SJ, Iwata A, Liu TT, Huang X, Briseño CG, Grajales-Reyes GE, Wöhner M, Tagoh H, Kee BL, Newberry RD, Busslinger M, Chang HY, Murphy TL, Murphy KM. Durai V, et al. Among authors: kee bl. Nat Immunol. 2019 Sep;20(9):1161-1173. doi: 10.1038/s41590-019-0450-x. Epub 2019 Aug 12. Nat Immunol. 2019. PMID: 31406378 Free PMC article.
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.
Parseghian CM, Loree JM, Morris VK, Liu X, Clifton KK, Napolitano S, Henry JT, Pereira AA, Vilar E, Johnson B, Kee B, Raghav K, Dasari A, Wu J, Garg N, Raymond VM, Banks KC, Talasaz AA, Lanman RB, Strickler JH, Hong DS, Corcoran RB, Overman MJ, Kopetz S. Parseghian CM, et al. Among authors: kee b. Ann Oncol. 2019 Feb 1;30(2):243-249. doi: 10.1093/annonc/mdy509. Ann Oncol. 2019. PMID: 30462160 Free PMC article.
The transcription factor BCL-6 controls early development of innate-like T cells.
Gioulbasani M, Galaras A, Grammenoudi S, Moulos P, Dent AL, Sigvardsson M, Hatzis P, Kee BL, Verykokakis M. Gioulbasani M, et al. Among authors: kee bl. Nat Immunol. 2020 Sep;21(9):1058-1069. doi: 10.1038/s41590-020-0737-y. Epub 2020 Jul 27. Nat Immunol. 2020. PMID: 32719520 Free PMC article.
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
Hong DS, Morris VK, El Osta B, Sorokin AV, Janku F, Fu S, Overman MJ, Piha-Paul S, Subbiah V, Kee B, Tsimberidou AM, Fogelman D, Bellido J, Shureiqi I, Huang H, Atkins J, Tarcic G, Sommer N, Lanman R, Meric-Bernstam F, Kopetz S. Hong DS, et al. Among authors: kee b. Cancer Discov. 2016 Dec;6(12):1352-1365. doi: 10.1158/2159-8290.CD-16-0050. Epub 2016 Oct 11. Cancer Discov. 2016. PMID: 27729313 Free PMC article.
In-vitro models of B-lineage commitment.
Kee BL, Paige CJ. Kee BL, et al. Semin Immunol. 1995 Jun;7(3):143-54. doi: 10.1016/1044-5323(95)90042-x. Semin Immunol. 1995. PMID: 7579201 Review.
172 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page